HHHamid Hashemi-Moghaddam

Hamid Hashemi-Moghaddam

*This is an algorithmically generated author record based on publicly available information.

Hamid Hashemi-Moghaddam has a total of 202 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Assessment of Novel Core–Shell ZIF-8@poly L-DOPA Nanoparticles for Targeted Doxorubicin Delivery

    by Mohammad Amin Damyar, Azadeh Serri, Hamid Hashemi-Moghaddam, Farzad Kahrizi

    Drug delivery systems using nanoparticles can deliver to tumor cells without affecting normal cells. In this study, a novel nano composite was synthesized by coupling abilities of ZIF-8 MOF and poly L-DOPA molecular imprinted polymer. Thus, a selective drug delivery system was designed for potential cancer treatment. A new nanocomposite, poly 3,4-dihydroxy-l-phenylalanine/ZIF-8 (L-DOPA/ZIF-8), was synthesized and used for targeted Doxorubicin delivery. The structural, morphological, and fluorescence properties of the synthesized samples were investigated by FT-IR, FE-SEM, and spectrofluorimetry. The investigation and characterization of the prepared ZIF-8@poly(dopa)/DOX sample indicated its layered and porous structure. The fluorescence emission spectrum showed that adding doxorubicin led to an increase in emission intensity, marking the successful loading of DOX. The safety and cytotoxicity of the prepared nanocomposite were investigated using the MTT method using the HEK293 cell line. The results show that the nanocomposite can be a biocompatible and safe nanocarrier in drug delivery applications. The drug release rate was investigated at two different pH levels, 7.4 and 5. The cumulative or total release of DOX from ZIF-8@poly(dopa)/DOX nanocomposite at pH 7.4 and 5.4 is 56.7 and 78.4%, respectively. Thus, this nanocarrier can be a suitable carrier for slow and controlled drug release into cancer cells.


  • Contributors

    by Hani Nasser Abdelhamid, Khursheed Ahmad, M.A. Almessiere, S. Analisa, Robson Teixeira Araujo, S. Ashok Kumar, Abdullah M. Asiri, Keziban Atacan, A. Baykal, Amarpreet K. Bhatia, et al.

  • An Experimental Study on The Oxidative Status and Inflammatory Levels of A Rat Model of Polycystic Ovary Syndrome Induced by Letrozole and A New High-Fat Diet.

    by Seyyede Fahimeh Mirseyyed, Saeed Zavareh, Meysam Nasiri, Hamid Hashemi-Moghaddam

    Although there are numerous animal models of polycystic ovary syndrome (PCOS), they often fail to accurately replicate the reproductive and metabolic phenotypes associated with PCOS. The objective of this study is to assess oxidative status and inflammatory levels in a rat model of PCOS subjected to a new high-fat diet (HFD) in combination with letrozole. In this experimental study, mature, six-week-old female Sprague-Dawley rats (n=20) were divided into four groups: control (standard diet); letrozole (letrozole plus a standard diet); HFD; and letrozole+HFD. After 16 weeks, the rats underwent vaginal smear analysis, measurement of hormonal and lipid profiles, and an oral glucose tolerance test (OGTT). Ovarian tissue morphology, oxidative parameters, and inflammatory status were evaluated. The experimental groups exhibited anoestrus profiles in the vaginal smears and abnormal ovarian morphology, which was not observed in the control group. Steroid hormone levels were significantly higher in the letrozole+HFD group compared to the other groups (P=0.00). The experimental groups also showed abnormal glucose levels and lipid metabolism. The relative expression levels of inflammatory genes were significantly elevated in the experimental groups compared to the control group (P=0.00), and the letrozole+HFD group exhibited the highest expression level (P=0.00). The HFD, letrozole, and letrozole+HFD groups demonstrated significantly increased levels of malondialdehyde (MDA) and reactive oxygen species (ROS), while the levels of enzymatic antioxidants were significantly reduced compared to the control group (P=0.00). The combination of a new HFD and letrozole treatment induces inflammation and oxidative stress (OS) in a rat model of PCOS. This model accurately exhibits abnormal metabolic phenotypes and disruptions in hormonal profiles associated with PCOS.


  • Graphene quantum dots coated cationic polymer for targeted drug delivery and imaging of breast cancer

    by Mahdi Mirzababaei, Kambiz Larijani, Hamid Hashemi-Moghaddam, Zohreh Mirjafary, Hamid Madanchi


  • Synergistic Effect Evaluation of Magnetotherapy and a Cationic–Magnetic Nanocomposite Loaded with Doxorubicin for Targeted Drug Delivery to Breast Adenocarcinoma

    by Alireza Naghaviyan, Hamid Hashemi-Moghaddam, Saeed Zavareh, Mahboobeh Ebrahimi Verkiani, Anja Meuller

    This work investigates the synergistic effect of magnetotherapy and a novel cationic-magnetic drug delivery system on inhibiting breast cancer cell growth and other tissues. First, super-paramagnetic magnetite (Fe3O4) nanoparticles were coated with doxorubicin-imprinted poly(methacrylic acid-co-diallyl dimethylammonium chloride) [Fe3O4/poly(MAA-DDA)]. The cationic-magnetic nanocomposite (CMC) was characterized using XRD, FT-IR, VSM, TGA, TEM, FESEM, EDS, DLS, and BET. In vitro analyses, including drug release kinetics, cytotoxicity, and hemolytic assays, confirmed this novel CMC's good drug release profile and biocompatibility. Finally, in vivo experiments on BALB/c mice were designed to evaluate the synergistic effect of magnetotherapy on targeted drug delivery using the CMC. In vivo fluorescence imaging evaluated the drug distribution in different tissues of mice. Tumor volume evaluation demonstrated the efficiency of the CMC and magnetotherapy in preventing tumor growth; the two techniques significantly reduced tumor volume. Histopathological analysis proved that applying magnetotherapy in conjunction with the cationic-magnetic drug delivery system significantly prevented tumor cell proliferation and increased apoptosis with limited impact on other tissues. Also, Dox and Fe concentrations in different tissues confirmed the efficient drug delivery to tumor cells.


  • Evaluation of Chemical Composition of Vaccaria oxyodontha Boiss Plant Essential Oils and Antioxidant and Antibacterial Effects on Gram-Negative and Gram-Positive Bacteria

    by Rahele Bahrami, Maryam Soori, Hossein Abbaspour, Hamid Hashemi-Moghaddam, Taghi Lashkarbolouki, Reza Moradi, Ahmad Reza Yari

    Background & Aims: Caryophyllaceae is a large family of about 2200 herbaceous or subshrub species. Vaccaria oxyodontha Boiss is of the family Caryophyllaceae. This plant grows as a weed in agricultural land of sugarcane, wheat, barley, forage, and summer crops such as sugar beet, potato, cotton, and onion. All parts of the V. oxyodontha Boiss plant, especially its root, contain a type of saponin, which shows its medicinal value. According to traditional Iranian medicine, this plant is a blood purifier and has anti-infective, utilized for cough, anti-rheumatism, and anti-inflammatory properties. This study first aimed to investigate the chemical composition of V. oxyodontha Boiss essential oil (EO) and the antioxidant and antibacterial properties of the hydroalcoholic extract of this plant on gram-positive and gram-negative bacteria. Materials and Methods: In this study, EOs were extracted from the aerial parts of V. oxyodontha Boiss using the combination of hydrodistillation and microwave-assisted hydrodistillation methods. Then, the antioxidant properties and antibacterial activity of the extract were evaluated, and the chemical compositions of the EOs of V. oxyodontha Boiss were determined using gas chromatography-mass spectroscopy (GC-MS). The extract’s antioxidant activity was studied by the 2,2-diphenyl-1- picrylhydrazyl-hydrate (DPPH) method. In addition, the plant antimicrobial effects were investigated by the agar disk diffusion method, and minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) were determined as well. Finally, the antibacterial activity of the mentioned plant was compared with the antibiotic discs of gentamicin (10 mg) and vancomycin (30 mg). Results: The major compounds in the EOs were 2-Pentadecanone,6,10,14-trimethyl (10.52%) and 1,2-Benzenedicarboxylic acid (19.27%). Half maximal inhibitory concentration (IC50) of V. oxyodontha Boiss was 0.49 µg/mL, which was higher than that of vitamin C (IC50 value of 0.56 µg/mL). Further, MIC and MBC for the V. oxyodontha Boiss extract against Staphylococcus aureus and Escherichia coli were 62.5 and 125 mg/mL, as well as 31.25 and 62.5 mg/mL, respectively. Conclusion: The results of GC-MS demonstrated that the EO of the V. oxyodontha Boiss plant contains antioxidant and antibacterial compounds. Its antioxidant properties are higher than vitamin C. The highest diameter of the inhibition zone caused by the methanol extract of the V. oxyodontha Boiss plant was against S. aureus and E. coli (23.7±0.29 mm and 15.65±0.33 mm, respectively). Compared with the antibiotics vancomycin, the Vaccaria oxyodontha Boiss represented a stronger inhibitory effect in the inhibition of S. aureus (P<0.05).